Cancer-Targeting Compound 1
Cancer-Targeting Compound 1 is used in the research of hormone- related cancer, extracted from patent WO 2008021331 A2.
Product Specifications
CAS Number
[1007581-62-5]
UNSPSC
12352005
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Benzonitrile,_4-[2-_4,4-dimethyl-2-oxo-3-oxazolidinyl_-4-thiazolyl]-.html
Purity
98.37
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(C2=CSC(N3C(OCC3(C)C)=O)=N2)C=C1
Molecular Formula
C15H13N3O2S
Molecular Weight
299.35
References & Citations
[1]Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6388454-01 0.1 mL
PARK2 (E3 Ubiquitin-protein Ligase Parkin, PRKN, Parkinson Juvenile Disease Protein 2, Parkinson Disease Protein 2) (MaxLight 490)
Ask
View Details MBS6388454-02 5x 0.1 mL
PARK2 (E3 Ubiquitin-protein Ligase Parkin, PRKN, Parkinson Juvenile Disease Protein 2, Parkinson Disease Protein 2) (MaxLight 490)
Ask
View Details 